EX-FILING FEES 4 ss3056390_ex0107.htm FILING FEE TABLE

 

 

EXHIBIT 107

 

 

Calculation of Filing Fee Table

 

Form S-8

(Form Type)

 

GENMAB A/S

(Exact Name of Registrant as Specified in its Charter)

 

Security

Type

Security Class Title(1) Fee Calculation Rule Amount Registered Proposed
Maximum
Offering Price
Per Share
Maximum Aggregate
Offering Price
Fee Rate Amount of
Registration Fee
Equity Ordinary shares, DKK 1 nominal value per share (“Ordinary Shares”)(1)(2) reserved for issuance under the Genmab A/S 2021 Restricted Stock Units Program Rule 457(c) and Rule 457(h) 250,000 $ 286.03(3) $71,507,500 $0.00014760 $10,554.51
Equity Ordinary Shares, DKK 1 nominal value per share (“Ordinary Shares”)(1)(2) reserved for issuance under the Genmab A/S 2021 Warrant Scheme Rule 457(c) and Rule 457(h) 120,000 $ 286.03(3) $34,323,600 $0.00014760 $5,066.16
Total Offering Amounts $456,000,000   $15,620.67
Total Fee Offsets     --
Net Fee Due     $15,620.67

 

     
  (1) Represents Ordinary Shares issuable under the Genmab A/S 2021 Warrant Scheme and Genmab A/S 2021 Restricted Stock Units Program. In addition, this Registration Statement also relates to such indeterminable number of additional Ordinary Shares as may be issuable pursuant to stock splits, stock dividends or similar transactions.

 

  (2) The Ordinary Shares may be represented by the Registrant’s American Depositary Shares (“ADS”), each of which represents one tenth of one Ordinary Share. The ADSs have been registered under a registration statement on Form F-6, filed with the Commission on May 22, 2013, as amended by Post-Effective Amendment No. 1, filed with the Commission on April 13, 2018, and Post-Effective Amendment No. 2, filed with the Commission on July 15, 2019.

 

  (3) The price of the Ordinary Shares underlying the warrants and the restricted stock units registered under this Registration Statement is estimated pursuant to Rule 457(c) and 457(h) under the Securities Act, solely for the purpose of computing the registration fee, based on the average of the high and low sales prices of the Ordinary Shares listed on Nasdaq Copenhagen on February 16, 2024 and on the exchange rate of DKK 6.92 per $1.00 as published by Danmarks Nationalbank on February 16, 2024.